4.3 Review

Dendrimers in Cancer Therapeutics and Diagnosis

Journal

CURRENT DRUG METABOLISM
Volume 13, Issue 8, Pages 1097-1109

Publisher

BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/138920012802850010

Keywords

Dendrimer; anticancer drug delivery; cancer diagnosis

Funding

  1. Shanghai Pujiang Program [09PJ1400600]
  2. National Natural Science Foundation of China [20974019]
  3. National Basic Research Program of China (973 Program) [2007CB936000]
  4. Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning
  5. Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry
  6. Shanghai Natural Science Foundation [10ZR1400800]

Ask authors/readers for more resources

Dendrimers represent a class of monodispersed synthetic macromolecules with a well defined three-dimensional structure of nanometer dimension in which a series of layered branches regularly extend from a central core molecule. Due to their precise nanoscale sizes, well-defined branched structures, and various surface modifications, dendrimers have been extensively investigated in a wide range of applications in the biomedical field, particularly in the therapeutics and diagnosis of cancer. This article gives an overview of the recent advances of dendrimers and dendrimer-based hybrid nanoparticles for cancer therapeutics and diagnosis applications.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available